Yes, you can get disability for HIV. Since 2017, the Social Security Administration (SSA) no longer lists HIV infection as an automatic qualifying impairment, but applicants still win benefits by proving the virus or its treatment causes severe functional limits. Approval usually rests on CD4 counts, opportunistic infections, or treatment side effects, not the diagnosis alone. Most successful claims now fall under residual functional capacity (RFC) assessments, immune-function evidence, or residual disease complications rather than a single lab value.
How the SSA Evaluates HIV: The Mechanism
The SSA's disability determination is a five-step sequential evaluation. At step three, the agency checks whether your condition matches a "listing," a fixed severity threshold in the Blue Book. HIV once had its own listing, but the SSA removed it in 2017 because antiretroviral therapy (ART) transformed HIV into a manageable chronic condition for most people. The replacement is found in Section 14.00 for immune system disorders.
This removal matters more than most explainers admit. It shifted thousands of decisions from a "meets or equals" lab test to a subjective functional review.
Under the current framework, a claim proceeds in this order. First, the SSA asks whether you are working above the substantial gainful activity (SGA) level, which is USD 1,620 per month in 2026 for non-blind applicants. Second, it screens for a severe impairment lasting 12 months or expected to result in death. Third, it compares your HIV-related limitations against the immune-system listing criteria.
Fourth, it assesses residual functional capacity, meaning what you can still do physically and mentally. Fifth, it applies the medical-vocational grid to decide whether jobs exist that you can perform. The decisive question is rarely whether you have HIV. It is how much the disease and its treatment reduce your ability to work eight hours a day, five days a week.
The mechanism behind approval is key. HIV itself is now rarely disabling. What disables people is one of three pathways: immune suppression severe enough to invite opportunistic disease, permanent organ damage from the virus or medication, or treatment side effects that impair stamina, cognition, or mobility. In plain terms: the SSA is not paying you for the diagnosis. It is paying you for the functional loss the diagnosis produces.
HIV Disability Criteria: CD4 Counts and Listing Thresholds
The immune-system listing uses specific markers. A CD4 count is the number of CD4 T-cells per cubic millimeter of blood. A healthy adult typically runs 500 to 1,500 cells. HIV progressively depletes this population, and the SSA's thresholds track the point where immune defense collapses.
The listing framework treats a CD4 count at or below 50 cells as presumptively severe. Counts in the 50 to 200 range can qualify when paired with recurrent infections or a poor response to treatment. A CD4 percentage below 14 percent is treated as roughly equivalent to the low-count threshold. A viral load, by contrast, is not itself a listing criterion, though a persistently high load despite adherence supports the argument that treatment is failing.
To reconcile the thresholds in one sentence: total CD4 counts below 200 define clinical AIDS, counts below 50 define the SSA's most severe immune-suppression tier, and a CD4 percentage under 14 percent is used as an alternate marker when absolute counts are unreliable.
The SSA also weighs infections that define advanced disease, sometimes called AIDS-defining illnesses. These include Pneumocystis pneumonia, cytomegalovirus disease, disseminated tuberculosis, and certain lymphomas. A single qualifying episode can anchor a claim, but the SSA now asks whether that episode is expected to last 12 months or recur.
One non-obvious detail: a very low viral load can actually complicate a claim. If ART is working well, the record shows viral suppression and preserved CD4 counts, which undercuts the argument that HIV limits your function. This counterintuitive reality is why most modern approvals hinge on side effects and organ damage rather than the virus's raw numbers.
What Actually Drives Approval: Quantified Context
The approval rate for HIV-related claims is far lower than most applicants expect. Nationwide, the SSA approves roughly 30 to 35 percent of initial disability applications across all conditions. HIV-specific claims historically tracked higher before 2017, when the listing still applied. Post-2017 data suggest HIV-primary claims now approximate or fall slightly below the general average, because many cases no longer meet step-three criteria and must survive functional review.
The decisive factor is residual functional capacity. In practice, an applicant who can sit, stand, and concentrate for a full workday rarely wins. Applicants who win typically show documented limits: fatigue requiring daytime rest, cognitive impairment affecting attention, or neuropathy limiting standing and walking.
A quantified comparison helps. Among approved HIV claims, experts report that the majority cite at least one non-immune-system impairment, such as peripheral neuropathy, chronic kidney disease, or major depression. Fewer than one in five approvals rest solely on immune markers. That single statistic reframes the whole strategy: build the record around function and comorbidities, not just the CD4 number.
The 12-month duration requirement is another filter. Short-term illness, even severe, does not qualify unless it is expected to last a year or result in death. Applicants with transient infections or recently started ART often fail this test.
Timeline: From Diagnosis to Decision
The time course of an HIV disability claim is long and predictable. Understanding the timeline prevents surprise and helps you plan finances.
| Stage | Typical duration | What happens |
|---|---|---|
| Diagnosis to application | 1 to 12 months | Records accumulate; you decide when symptoms justify filing |
| Initial application review | 3 to 6 months | SSA and state agency review medical evidence |
| Initial decision | day 90 to 180 | Approval or denial issued |
| Reconsideration (if denied) | 3 to 5 months | Second review, most denied again |
| Hearing request and wait | 12 to 24 months | ALJ hearing scheduled; largest backlog stage |
| Hearing to decision | 1 to 3 months | Judge issues written decision |
| Appeals Council (if needed) | 6 to 12 months | Final administrative review |
From diagnosis to a final favorable decision, a contested case commonly runs 18 to 30 months. The 12-month severity requirement and the multi-stage appeals process are the two biggest time sinks.
Variations and Edge Cases
Not every HIV case looks alike, and the edge cases decide many claims.
Treatment side effects. Older ART regimens caused lipodystrophy, neuropathy, and kidney toxicity. Modern regimens are gentler, but some still produce fatigue, gastrointestinal problems, and metabolic changes. Documented side effects that limit function can support an RFC finding even with a high CD4 count.
Cognitive impairment. HIV-associated neurocognitive disorder (HAND) affects a minority of people with HIV, more often those with long-standing infection or poor viral control. HAND can impair memory, processing speed, and concentration, which directly limits skilled work. Mental status testing in the record is powerful evidence.
Comorbidities. Hepatitis B and C coinfection, cardiovascular disease, and chronic kidney disease are more common in people with HIV. These conditions often carry their own listings and can independently justify approval.
Aging. People with HIV experience accelerated aging of the immune system, a phenomenon sometimes called inflammaging. A 55-year-old with HIV may have the functional profile of a 65-year-old, an edge case the medical-vocational grid can sometimes capture.
Pregnancy and episodic illness. Conditions that flare and remit create evidentiary problems because the SSA wants 12 months of continuous limitation. Documenting the pattern, not just the worst day, is essential.
Common Misconceptions
Several beliefs lead applicants astray.
Misconception one: an HIV diagnosis automatically qualifies you. This was closer to true before 2017. It is false now. Diagnosis alone is not a listing, and most people with well-controlled HIV do not qualify.
Misconception two: an undetectable viral load means automatic denial. Not so. An undetectable load shows treatment is working, but it does not erase treatment side effects or organ damage. The record as a whole still matters.
Misconception three: a high CD4 count blocks any claim. Function, not a single lab value, drives the modern decision. Applicants with CD4 counts above 200 still win when comorbidities and functional limits are well documented.
Misconception four: you must be unable to work at all. The SSA standard is inability to perform substantial gainful activity, not total incapacity. Part-time work below the SGA threshold can coexist with a claim.
Misconception five: the process is fast if you are sick. The multi-stage timeline applies regardless of severity, and expedited processing is limited.
What to Actually Do: Building a Winning Claim
The strongest claims are built before the application is filed. Concrete steps matter more than paperwork volume.
- Start a symptom and side-effect diary now. Record fatigue levels, cognitive lapses, and pain with dates. The SSA weighs contemporaneous records far more than recollection.
- Ask your HIV specialist to document functional limits, not just lab values. A note stating "cannot sustain eight-hour work due to fatigue" is worth more than a normal CD4 count.
- Gather complete treatment history, including every regimen and every documented side effect. Gaps invite the assumption that treatment is uncomplicated.
- Obtain objective testing for cognitive concerns. A formal neuropsychological evaluation converts vague complaints into measurable deficits.
- File a function report describing a typical day. Concrete detail about rest breaks, household limits, and concentration lapses is the backbone of an RFC finding.
- Consider legal representation before the hearing stage. The hearing is where most favorable decisions occur, and a representative improves outcomes at that step.
Red-flag warnings to watch for:
- Missing or incomplete medical records, which is the single most common cause of denial.
- A gap in treatment longer than a few months without explanation.
- Filing while earning above the SGA threshold, which triggers an automatic denial at step one.
- Describing limitations only in general terms, without dates or functional specifics.
- Relying on a diagnosis letter with no mention of work-related limits.
Limitations of the HIV Disability Process
The system has real constraints that honest readers should weigh.
The functional standard is subjective, and outcomes vary by state agency and administrative law judge. Two applicants with nearly identical records can receive different decisions. This inconsistency is a known weakness, not a rumor.
The evidence burden is heavy. The SSA needs records showing 12 months of limitation, and people with recently diagnosed or newly treated HIV often cannot meet that bar yet. Waiting can weaken the claim's start date but strengthen the evidence.
The 2017 listing removal was a deliberate policy choice based on treatment advances, and it is unlikely to reverse. Applicants should expect functional review and prepare for it rather than hoping for an automatic listing match.
Nothing here is legal or medical advice, and the thresholds above reflect published criteria that change. Verify current figures with the SSA and consult a disability attorney or your HIV specialist before filing.